logo

For the Inventor, By the Inventor

Biel-Benken, Switzerland

Wilhelm Kump

USPTO Granted Patents = 13

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 46(Granted Patents)


Company Filing History:

goldMedal13 out of 6,858 
 
Ciba-Geigy Corporation
 patents

Years Active: 1977-1993

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5180718 - Acyl derivatives of oxazolorifamycins (1993-01-19),
2. 5147870 - Substituted azacyclohexyl derivatives (1992-09-15),
3. 5100894 - Open chain rifamycin derivatives (1992-03-31),
4. 5053510 - Process for the preparation of polycyclic compounds (1991-10-01),
5. 5003070 - Substituted azacyclohexyl derivatives of rifamycins (1991-03-26),
6. 4918066 - Substituted 4-benzylpiperazinyl compounds (1990-04-17),
7. 4916126 - Diacyl derivatives of 4-(trialkylbenzyl)-piperazinyl compounds (1990-04-10),
8. 4379149 - Process for introducing an oxygen-containing functional group into (1983-04-05),
9. 4353826 - Substituted rifamycins (1982-10-12),
10. 4322419 - Bicyclomycin derivatives, compositions thereof and process of use thereof (1982-03-30),
11. 4261891 - Antibiotically active rifamycin derivatives (1981-04-14),
12. 4145344 - Bicyclomycin derivatives (1979-03-20),
13. 4005077 - Antibiotically active compounds (1977-01-25),

Title: The Innovative Mind of Wilhelm Kump

Introduction

Wilhelm Kump, a prolific inventor based in Biel-Benken, Switzerland, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 13 patents, Kump has been at the forefront of innovative research, particularly focused on the development of novel compounds with therapeutic potential.

Latest Patents

Kump's latest inventions include groundbreaking research on acyl derivatives of oxazolorifamycins. This invention involves new acyl derivatives of rifamycins, designed to enhance their efficacy in medicinal applications. The structurally complex formulas developed by Kump also allow for the creation of compounds that can be used in various medicinal formulations, including those with specific active properties. Another notable patent from Kump details the preparation of substituted azacyclohexyl derivatives, which also exhibit valuable pharmacological properties. These innovations demonstrate his commitment to advancing drug development and finding new solutions in medicine.

Career Highlights

Kump has spent his career working with the Ciba-Geigy Corporation, a company known for its innovation in the chemical and pharmaceutical industries. His contributions have led to advancements not only in patented formulations but also in practical applications that benefit health and well-being. His focus on pharmacologically active compounds reflects the broader goals of the industry to improve therapeutic options available to patients.

Collaborations

Throughout his career, Kump has collaborated with notable colleagues including Hans Bickel and Jen Chen. These partnerships have facilitated the exchange of ideas and methodologies, enhancing the quality and impact of their research outputs. Together, they have explored new avenues in pharmaceutical innovations and have collectively contributed to the success of their projects at Ciba-Geigy Corporation.

Conclusion

Wilhelm Kump stands out as an influential figure in the realm of drug innovation. His 13 patents are a testament to his dedication and ingenuity in the field of pharmaceuticals. As he continues to push the boundaries of medicinal chemistry, Kump's work is expected to have lasting implications for healthcare advancements. His contributions not only reflect individual brilliance but also the power of collaboration in driving scientific and technological progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…